氨溴特罗口服液佐治儿童支气管肺炎临床分析  

Observation of the effect of ambroxol and clenbuterol oral solution in the treatment of children with bronchopneumonia

作　　者：马敬斌[1] 盛方红[1] 王道方[1] MA Jing-bin;SHENG Fang-hong;WANG Dao-fang(The second people’s hospital of Liaocheng, Shandong 252600, China)

机构地区：[1]聊城市第二人民医院,山东聊城252600

出　　处：《中国处方药》2017年第2期107-108,共2页Journal of China Prescription Drug

摘　　要：目的观察氨溴特罗口服液佐治儿童支气管肺炎的临床疗效。方法将180例支气管肺炎患儿分为对照组90例和治疗组90例,对照组给予青霉素和头孢菌素,青霉素过敏者或肺炎支原体、肺炎衣原体感染者用大环内酯类抗感染,同时给予止咳、化痰药物。治疗组在对照组治疗基础上加服氨溴特罗口服液,疗程5~7 d。观察两组患儿症状、体征恢复情况、消失时间及不良反应发生情况。结果治疗组咳嗽、咳痰、气喘、三凹征、肺部哮鸣音及湿啰音消失时间均较对照组缩短,差异均具统计学意义(P<0.05);治疗组的治疗总有效率高于对照组,差异具有统计学意义(P<0.05),未见明显不良反应。结论应用氨溴特罗口服液佐治支气管肺炎临床疗效确切,安全可靠。Objective To observe the clinical curative effect of ambroxol and clenbuterol oral solution in treatment of bronchial pneumonia in children.Methods 180 patients with bronchopneumonia were divided into control and treatment group, 90 cases in each. The control group gives the penicillin and the cephalosporin, Penicillin allergy or Mycoplasma pneumoniae, Chlamydia pneumoniae infection with macrolide antibiotics, at the same time giving cough,phlegm Drugs. Treatment group were treated with ambroxol and clenbuterol oral solution based on the additional services, treatment 5 ～ 7 d. Observation children symptoms, signs, recovery, lost time, and adverse reaction conditions in two groups. Results Treatment group, cough, sputum, asthma, Three depressions sign,wheeze and lung auscultation, recovery, lost time were shorter than the control group, there was a significant difference( P < 0.05). There was no obvious adverse reactions in two groups. Conclusion Clinical efficacy of ambroxol and clenbuterol oral solution added to the therapy is definite, safe and reliable, which is worth clinical application.

关 键 词：氨溴特罗口服液 支气管肺炎 儿童 

分 类 号：R725.6[医药卫生—儿科]